489 related articles for article (PubMed ID: 23693133)
21. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.
Zwan MD; Villemagne VL; Doré V; Buckley R; Bourgeat P; Veljanoski R; Salvado O; Williams R; Margison L; Rembach A; Macaulay SL; Martins R; Ames D; van der Flier WM; Ellis KA; Scheltens P; Masters CL; Rowe CC
J Alzheimers Dis; 2016; 49(4):1115-22. PubMed ID: 26639956
[TBL] [Abstract][Full Text] [Related]
22. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
23. Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly.
Dhilla Albers A; Asafu-Adjei J; Delaney MK; Kelly KE; Gomez-Isla T; Blacker D; Johnson KA; Sperling RA; Hyman BT; Betensky RA; Hastings L; Albers MW
Ann Neurol; 2016 Dec; 80(6):846-857. PubMed ID: 27696605
[TBL] [Abstract][Full Text] [Related]
24. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
25. Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study.
Faux NG; Ellis KA; Porter L; Fowler CJ; Laws SM; Martins RN; Pertile KK; Rembach A; Rowe CC; Rumble RL; Szoeke C; Taddei K; Taddei T; Trounson BO; Villemagne VL; Ward V; Ames D; Masters CL; Bush AI
J Alzheimers Dis; 2011; 27(4):909-22. PubMed ID: 21891867
[TBL] [Abstract][Full Text] [Related]
26. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
27. The impact of subjective memory complaints on quality of life in community-dwelling older adults.
Maki Y; Yamaguchi T; Yamagami T; Murai T; Hachisuka K; Miyamae F; Ito K; Awata S; Ura C; Takahashi R; Yamaguchi H
Psychogeriatrics; 2014 Sep; 14(3):175-81. PubMed ID: 25142381
[TBL] [Abstract][Full Text] [Related]
28. Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal Aging.
Valech N; Mollica MA; Olives J; Tort A; Fortea J; Lleo A; Belén SS; Molinuevo JL; Rami L
J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S87-98. PubMed ID: 26445275
[TBL] [Abstract][Full Text] [Related]
29. Immediate story recall in elderly individuals with memory complaints: how much does it contribute to memory assessment?
Coutinho G; Drummond C; de Oliveira-Souza R; Moll J; Tovar-Moll F; Mattos P
Int Psychogeriatr; 2015 Oct; 27(10):1679-86. PubMed ID: 25765673
[TBL] [Abstract][Full Text] [Related]
30. Absence of a relationship between subjective memory complaint and objective memory impairment in mild cognitive impairment (MCI): is it time to abandon subjective memory complaint as an MCI diagnostic criterion?
Lenehan ME; Klekociuk SZ; Summers MJ
Int Psychogeriatr; 2012 Sep; 24(9):1505-14. PubMed ID: 22717042
[TBL] [Abstract][Full Text] [Related]
31. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
[TBL] [Abstract][Full Text] [Related]
32. Risk profiles of subtypes of mild cognitive impairment: the sydney memory and ageing study.
Sachdev PS; Lipnicki DM; Crawford J; Reppermund S; Kochan NA; Trollor JN; Draper B; Slavin MJ; Kang K; Lux O; Mather KA; Brodaty H;
J Am Geriatr Soc; 2012 Jan; 60(1):24-33. PubMed ID: 22142389
[TBL] [Abstract][Full Text] [Related]
33. The Diagnostic and Prognostic Value of a Dual-Tasking Paradigm in a Memory Clinic.
Nielsen MS; Simonsen AH; Siersma V; Hasselbalch SG; Hoegh P
J Alzheimers Dis; 2018; 61(3):1189-1199. PubMed ID: 29278887
[TBL] [Abstract][Full Text] [Related]
34. Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging.
Lui JK; Laws SM; Li QX; Villemagne VL; Ames D; Brown B; Bush AI; De Ruyck K; Dromey J; Ellis KA; Faux NG; Foster J; Fowler C; Gupta V; Hudson P; Laughton K; Masters CL; Pertile K; Rembach A; Rimajova M; Rodrigues M; Rowe CC; Rumble R; Szoeke C; Taddei K; Taddei T; Trounson B; Ward V; Martins RN; AIBL Research Group
J Alzheimers Dis; 2010; 20(4):1233-42. PubMed ID: 20413897
[TBL] [Abstract][Full Text] [Related]
35. Decreased serum zinc is an effect of ageing and not Alzheimer's disease.
Rembach A; Hare DJ; Doecke JD; Burnham SC; Volitakis I; Fowler CJ; Cherny RA; McLean C; Grimm R; Martins R; Ames D; Masters CL; Bush AI; Roberts BR
Metallomics; 2014 Jul; 6(7):1216-9. PubMed ID: 24676028
[TBL] [Abstract][Full Text] [Related]
36. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).
Lim YY; Jaeger J; Harrington K; Ashwood T; Ellis KA; Stöffler A; Szoeke C; Lachovitzki R; Martins RN; Villemagne VL; Bush A; Masters CL; Rowe CC; Ames D; Darby D; Maruff P
Arch Clin Neuropsychol; 2013 Jun; 28(4):320-30. PubMed ID: 23552802
[TBL] [Abstract][Full Text] [Related]
37. The memory alteration test (M@T) discriminates between subjective memory complaints, mild cognitive impairment and Alzheimer's disease.
Rami L; Bosch B; Sanchez-Valle R; Molinuevo JL
Arch Gerontol Geriatr; 2010; 50(2):171-4. PubMed ID: 19375179
[TBL] [Abstract][Full Text] [Related]
38. Differences in quantitative methods for measuring subjective cognitive decline - results from a prospective memory clinic study.
Vogel A; Salem LC; Andersen BB; Waldemar G
Int Psychogeriatr; 2016 Sep; 28(9):1513-20. PubMed ID: 27053171
[TBL] [Abstract][Full Text] [Related]
39. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status.
Albrecht MA; Szoeke C; Maruff P; Savage G; Lautenschlager NT; Ellis KA; Taddei K; Martins R; Masters CL; Ames D; Foster JK;
Neuropsychologia; 2015 Aug; 75():411-9. PubMed ID: 26102189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
